Unfortunately, this fixed property is subjected to the well-known ability of cancers to evolve resistance to a given therapy, in this case away from the vulnerable single tumor expressed monoclonal T cell receptor for Ag-peptide/MHC [32,33,34]. This evidence concerns the gene HLA-C and cancer.